- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2641EUR$2,950USD£2,249GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3088EUR$3,450USD£2,631GBP
- Report
- September 2023
- 101 Pages
North America
From €2641EUR$2,950USD£2,249GBP
- Report
- September 2023
- 194 Pages
Global
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2021
- 80 Pages
India
From €746EUR$833USD£635GBP
€1065EUR$1,190USD£907GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,775USD£3,518GBP
- Report
- August 2019
- 76 Pages
Global
€2686EUR$3,000USD£2,288GBP
- Report
- July 2018
- 224 Pages
Global
From €1611EUR$1,800USD£1,373GBP
- Report
- May 2025
- 99 Pages
Global
From €3500EUR$4,188USD£3,086GBP
- Report
- November 2024
- 78 Pages
Global
From €3500EUR$4,188USD£3,086GBP
- Report
- March 2025
- 92 Pages
Global
From €3500EUR$4,188USD£3,086GBP
- Report
- November 2024
- 86 Pages
Global
From €3500EUR$4,188USD£3,086GBP
- Book
- February 2025
- 432 Pages
- Book
- March 2024
- 528 Pages
- Book
- October 2018
- 240 Pages
- Book
- February 2015
- 400 Pages
- Book
- January 2015
- 464 Pages
- Book
- August 2012
- 552 Pages
- Book
- November 2008
- 312 Pages

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more